Otani Sakiko

Research field (1)： Respiratory medicine

Papers (31)：

Satoshi Ikeda, Terufumi Kato, Takashi Ogura, Akimasa Sekine, Tsuneyuki Oda, Noriyuki Masuda, Satoshi Igawa, Ken Katono, Sakiko Otani, Kouzo Yamada, et al. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016. BMC cancer. 2018. 18. 1. 241-241
Satoshi Igawa, Sakiko Otani, Yoshiro Nakahara, Shinichiro Ryuge, Yasuhiro Hiyoshi, Tomoya Fukui, Hisashi Mitsufuji, Masaru Kubota, Masato Katagiri, Yuichi Sato, et al. Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer. Investigational New Drugs. 2018. 36. 1. 45-52
Yoshiro Nakahara, Jiichiro Sasaki, Tomoya Fukui, Sakiko Otani, Satoshi Igawa, Kazushige Hayakawa, Noriyuki Masuda. The role of prophylactic cranial irradiation for patients with small-cell lung cancer. Japanese Journal of Clinical Oncology. 2018. 48. 1. 26-30
Hideyuki Niwa, Sakiko Otani, Norihiro Nakada, Jiichiro Sasaki, Hideo Saka, Noriyuki Masuda. Nab-paclitaxel plus carboplatin as an effective and safe chemotherapy regimen for pulmonary carcinosarcoma with interstitial lung disease: A case report. Respiratory Medicine Case Reports. 2018. 23. 131-135
Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara, Sakiko Otani, Satoshi Igawa, Masato Katagiri, Hisashi Mitsufuji, Masaru Kubota, Yasuhiro Hiyoshi, Mikiko Ishihara, et al. Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study. Clinical Lung Cancer. 2018

ｍore...

Education (1)：

1998 - 2004 Kitasato University School of Medicine

Work history (1)：

2006/04 - 2018/03 Kitasato University School of Medicine

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page